Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Celcuity | CELC | Nov 27, 2024 | 12.85 | -1.53 |
Celestica | CLS | Nov 27, 2024 | 83.16 | -4.05 |
Celldex Therapeutics | CLDX | Nov 27, 2024 | 27.89 | +4.22 |
Cellebrite | CLBT | Nov 27, 2024 | 19.89 | -0.20 |
Cellectar Biosciences | CLRB | Nov 27, 2024 | 1.53 | -1.92 |
Cellectis ADR | CLLS | Nov 27, 2024 | 2.13 | -0.47 |
Celsius | CELH | Nov 27, 2024 | 28.37 | +2.79 |
Celularity A | CELU | Nov 27, 2024 | 2.01 | -29.47 |
Cementos Pacasmayo ADR | CPAC | Nov 27, 2024 | 5.75 | +1.59 |
CEMEX ADR | CX | Nov 27, 2024 | 5.43 | -0.18 |
Cemtrex | CETX | Nov 27, 2024 | 3.21 | +0.31 |
Cencora | COR | Nov 27, 2024 | 249.69 | +0.50 |
Cenntro | CENN | Nov 27, 2024 | 1.19 | -1.65 |
Cenovus Energy | CVE | Nov 27, 2024 | 15.71 | +1.49 |
Centene | CNC | Nov 27, 2024 | 59.93 | -0.12 |
CenterPoint Energy | CNP | Nov 27, 2024 | 32.66 | +0.40 |
Centerra Gold | CGAU | Nov 27, 2024 | 5.99 | +1.35 |
Centerspace | CSR-C | Nov 27, 2024 | 24.98 | 0.00 |
Centessa Pharmaceuticals ADR | CNTA | Nov 27, 2024 | 17.60 | +1.73 |
Centrais Electricas Brasileiras B ADR | EBR-B | Nov 27, 2024 | 6.82 | -2.15 |
Centrais Eletricas Brasileiras ADR | EBR | Nov 27, 2024 | 6.01 | -4.60 |
Central Garden & Pet | CENT | Nov 27, 2024 | 40.16 | +0.83 |
Central Garden & Pet A | CENTA | Nov 27, 2024 | 34.13 | +1.10 |
Central Pacific Financial | CPF | Nov 27, 2024 | 32.39 | +0.50 |
Central Plains Bancshares | CPBI | Nov 27, 2024 | 14.40 | -0.35 |
Central Puerto ADR | CEPU | Nov 27, 2024 | 13.77 | -1.08 |
Central Securities | CET | Nov 27, 2024 | 46.82 | -0.17 |
Centrus Energy A | LEU | Nov 27, 2024 | 82.49 | +1.28 |
Centuri Holdings | CTRI | Nov 27, 2024 | 20.37 | -1.64 |
Centurion Acquisition | ALFUU | Nov 27, 2024 | 10.13 | +0.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.